Treace Medical appoints Lance Berry and Jane Kiernan to board effective Oct 1, 2022

TREACE MEDICAL CONCEPTS, INC.

Appointed Lance A. Berry (former Wright Medical CFO) and Jane E. Kiernan (CEO of Surgimatix) to board, effective Oct 1, 2022.
Berry will serve on Audit Committee; Kiernan on Compensation Committee.
Both qualify as independent directors under Nasdaq rules.
Berry brings ~20 years of medical device financial leadership; Kiernan has 30+ years of healthcare executive experience.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Jane E. Kiernan

Director

TMCI · TREACE MEDICAL CONCEPTS, INC.

Effective: 2022-10-01
Filed: September 28, 2022, 7:59 PM ET

On September 27, 2022, Treace Medical Concepts, Inc. (the “Company”) announced that the Board of Directors of the Company (the “Board”) has, based on the recommendation of the Board’s Nominating, Compliance and Governance Committee, appointed Lance A. Berry and Jane E. Kiernan to the Company’s Board effective October 1, 2022.

Appointed

Lance A. Berry

Director

TMCI · TREACE MEDICAL CONCEPTS, INC.

Effective: 2022-10-01
Filed: September 28, 2022, 7:59 PM ET

On September 27, 2022, Treace Medical Concepts, Inc. (the “Company”) announced that the Board of Directors of the Company (the “Board”) has, based on the recommendation of the Board’s Nominating, Compliance and Governance Committee, appointed Lance A. Berry and Jane E. Kiernan to the Company’s Board effective October 1, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Jane E. Kiernan was appointed as Director at TREACE MEDICAL CONCEPTS, INC..

Action: appointed
Role: Director

Exact text from the filing

On September 27, 2022, Treace Medical Concepts, Inc. (the “Company”) announced that the Board of Directors of the Company (the “Board”) has, based on the recommendation of the Board’s Nominating, Compliance and Governance Committee, appointed Lance A. Berry and Jane E. Kiernan to the Company’s Board effective October 1, 2022.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Lance A. Berry was appointed as Director at TREACE MEDICAL CONCEPTS, INC..

Action: appointed
Role: Director

Exact text from the filing

On September 27, 2022, Treace Medical Concepts, Inc. (the “Company”) announced that the Board of Directors of the Company (the “Board”) has, based on the recommendation of the Board’s Nominating, Compliance and Governance Committee, appointed Lance A. Berry and Jane E. Kiernan to the Company’s Board effective October 1, 2022.

View on SEC.gov

TREACE MEDICAL CONCEPTS, INC. filing history →

Source: SEC EDGAR

accession 0000950170-22-018920

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.